3 hours ago
3
MarketBeat
Sun, March 15, 2026 astatine 4:33 PM CDT 7 min read
-
Protocol amendments—T1 re-resection, TA reinduction, and requiring biopsy confirmation—plus reinduction of nonresponders contributed to improved effect rates, and absorption expects 12-month data successful the second fractional of this year with a Q2 technological update possible.
-
Following FDA feedback the institution shifted the superior endpoint from CR astatine six months to CR astatine immoderate time, reporting an interim "in the 60s" CR-any-time complaint successful a pivotal cohort of astir 125 patients.
-
enGene has regulatory momentum with RMAT and CDRP designations, is nearing completion of PPQ/validation batches and Module 3 preparation, and expects a potential support successful 2027 with currency runway into the second fractional of 2028; commercially it emphasizes a non-viral, easy-storage therapy aimed astatine assemblage urologists and a buy-and-bill model.
-
Interested successful enGene Holdings Inc.? Here are 5 stocks we similar better.
Executives from enGene (NASDAQ:ENGN) provided an update connected the company’s detalimogene programme successful non-muscle invasive bladder crab (NMIBC), discussing caller protocol changes, regulatory interactions, and commercialized readying arsenic the survey advances.
In discussing modifications to the NMIBC proceedings protocol, the institution highlighted 3 changes: T1 re-resection, TA reinduction, and a displacement toward biopsy confirmation earlier removing a diligent from the study. Management characterized these arsenic “standard of care” steps intended to align the proceedings much intimately with emblematic urologist practice.
→ Broadcom’s AI Momentum Could Be Far From Over
When asked which amendment contributed astir to the betterment observed successful six-month implicit effect (CR) rate, the institution emphasized that the result apt reflected a operation of factors alternatively than a azygous change. Management noted the comparatively tiny size of NMIBC datasets (typically 70 to 100 patients), wherever results tin beryllium meaningfully affected by a tiny fig of patients. In summation to protocol adjustments, the institution pointed to changes successful objective proceedings execution, including antithetic oversight and operational approach, arsenic contributing to improved effect rates.
Regarding the power from ocular content to biopsy, the institution said allowing investigators to region patients based connected ocular appraisal unsocial could beryllium confounded by bladder inflammation oregon redness, which tin hap with immunotherapy. The institution said biopsy confirmation amended reflects modular signifier and has had a affirmative effect connected efficacy rates.
→ Amazon Is Rising While the Market Falls—Here’s Why
English (CA) · 
English (US) · 
Spanish (MX) ·